Thanks! We’re so glad you’re here!

We’ll keep you posted on the future of pet cancer care with our email newsletter.

Until the next delivery, check out some of our latest articles below.

Check Out Our Recent Posts

More Than a Cancer Vaccine

The ELIAS Cancer Immunotherapy (ECI®) if the first and only USDA-approved product for the treatment of canine osteosarcoma. ECI® is unique because of its dual approach to treatment: it brings together the power of a personalized cancer vaccination and activated “killer” T cell therapy to trigger the patient’s own immune system to attack cancer cells. Our immunotherapy enables veterinary care providers like you to:

Extend hope for families of pets with cancer

Make a measurable difference for your patients

Help improve outcomes with minimal adverse side effects

Talk with an ELIAS Animal Health Expert Today